title: Update of the Belgian Association for the Study of the Liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors.
authors.affiliation: Department of Gastroenterology and Hepatology, AZ St. Jan AV Brugge-Oostende, Binruges, Belgium. Hans.Orlent@azsintjan.be
authors.forename: Hans
authors.initials: H
authors.lastname: Orlent
authors.forename: Pierre
authors.initials: P
authors.lastname: Deltenre
authors.forename: Sven
authors.initials: S
authors.lastname: Francque
authors.forename: Wim
authors.initials: W
authors.lastname: Laleman
authors.forename: Christophe
authors.initials: C
authors.lastname: Moreno
authors.forename: Stefan
authors.initials: S
authors.lastname: Bourgeois
authors.forename: Isabelle
authors.initials: I
authors.lastname: Colle
authors.forename: Jean
authors.initials: J
authors.lastname: Delwaide
authors.forename: Stéphane
authors.initials: S
authors.lastname: De Maeght
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Mulkay
authors.forename: Peter
authors.initials: P
authors.lastname: Stärkel
authors.forename: Hendrik
authors.initials: H
authors.lastname: Reynaert
mesh_terms: D005838:Genotype; D016174:Hepacivirus / Q000235:genetics*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D009842:Oligopeptides / Q000627:therapeutic use*; D011392:Proline / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000627:therapeutic use*
chemical_list: D009842:Oligopeptides; D011480:Protease Inhibitors; C486464:telaprevir; C512204:N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide; D011392:Proline